Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post S&P 500 Rises from Bearish to Neutral, But Will It Last? April 28, 2025 Related Posts Deep-Sea Crisis: Can the ISA Regain Control of the Deep Ocean? May 3, 2025 Ontario Tables Sweeping Bill to Restrict Foreign Access to Critical Minerals May 3, 2025 Top 5 Canadian Mining Stocks This Week: Lion Rock Jumps 60 Percent May 3, 2025